TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06611579: Clinical Study of the inQB8 TTVR System (The MonarQ Study)

Sponsor: inQB8 Medical Technologies, LLC · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 50 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,261,600

Rescue Site Savings

+$830,000

Unlock Full NCT06611579 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06611579 Rescue Dossier →